Clinical Trial Update: MMA Embolization for Refractory Chronic Migraine [NA]

View source ↗

Summary

Clinical trial update indicates ongoing recruitment for meningeal artery embolization as a treatment for refractory chronic migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. | Conditions: Migraine | NA | Status: RECRUITING